By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
A reflux diagnosis test is crucial to the investigation and ongoing treatment of a problem since it offers information regarding gastro-oesophageal reflux and helps identify whether it is the source of your symptoms. A tiny tube (catheter) is inserted through your nose, down the oesophagus, and into the stomach during the reflux testing.
To make the catheter passage more comfortable, a topical anaesthetic will be given to the nose. The recording device that you will take home with you and wear around your waist for around 24 hours is connected to the catheter. Breathing, talking, or swallowing won’t be impacted by the test during this time.
The Global reflux testing system market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
By measuring the frequency and duration of acid reflux, the Bravo reflux testing device offers a novel way for doctors to better comprehend patient symptoms. The Bravo reflux testing device is a cutting-edge ambulatory pH test based on a capsule that records esophageal pH data for up to 96 hours.
In comparison to a 24-hour catheter-based test, an extended 96-hour recording period yields four times the amount of data,and permits the assessment of patients off PPI therapy, which is clinically advantageous in patients with intractable GERD. Patients prefer and can tolerate catheter-free designs better enabling medical professionals to record links between symptoms and instances of acid reflux.
During the projection period, it is anticipated that the global market for reflux testing products will expand considerably. GERD can be brought on by a variety of lifestyle-related variables, including drunkenness, the intake of unhealthy foods and beverages, stress, and more. This is one of the main driving forces for the expansion of the global market for reflux testing products.
With an increase in the number of elderly people, acid reflux is expected to become more common in places like Asia Pacific, Europe, and North America. Few percent of Americans have GERD, according to the National Institute of Diabetes and Digestive and Kidney Diseases. This constantly growing patient base is a significant element anticipated to fuel the expansion of the global market for reflux testing products throughout the coming years.
